Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Asthma (GATA-3)
Part of paid clinical trials in Nashville, Tennessee.
- Sponsor
- Vanderbilt University Medical Center
- Study ID
- NCT05254314
- Phase
- PHASE2
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Semaglutide Pen Injector 2.4mg weekly — DRUGOnce weekly subcutaneous injection
- Placebo — OTHEROnce weekly subcutaneous injection
Study Details
This is a randomized placebo-controlled trial of semaglutide, an FDA-approved therapy for the treatment of type 2 diabetes mellitus and obesity, in adults with symptomatic asthma despite the use of inhaled steroids and with excess body weight. This study will test the central hypothesis that semaglutide will improve asthma control and reduce airway inflammation due to direct effects on the respiratory tract in adult asthma associated with obesity.
Key Dates
- Start date
- Oct 11, 2022
- Status verified
- May 2026
- Primary completion
- Sep 30, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Study Drug (Semaglutide)Semaglutide 2.4mg once weekly
- Placebo Comparator: PlaceboPlacebo 2.4mg once weekly
Primary Outcome Measure
The efficacy of semaglutide on asthma control questionnaire-7 score in subjects with symptoms, persistent asthma and obesity. [ Time Frame: Baseline to week 12 ]
Central Contacts
- Katherine Cahill, MD615-936-1269
- Deborah Hunter615-936-9123
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Vanderbilt University Medical Center | Nashville | Tennessee | 37203 | Katherine Cahill, MD (PRINCIPAL_INVESTIGATOR) Gordon Bernard, MD (SUB_INVESTIGATOR) Kevin Niswender, MD (SUB_INVESTIGATOR) Stoke Peebles, MD (SUB_INVESTIGATOR) Leonard B Bacharier, MD (SUB_INVESTIGATOR) |
Find similar trials in Nashville, TN
By condition
By specialty
By research site
Related Studies
- Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)PHASE3 · Recruiting · Sanofi · Phoenix, Arizona
- Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With AsthmaPHASE3 · Recruiting · AstraZeneca · Anchorage, Alaska
- Reducing Overuse of Antibiotics With Decision SupportRecruiting · Vanderbilt University Medical Center · Oakland, California
- Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled CorticosteroidsPHASE2 · Recruiting · AstraZeneca · Bakersfield, California